R&D

yellow light street light traffic pause slow delay

Pharma

Verastem mulls options on approved asset in pancreatic cancer

With solid but not stellar data on its approved oncology combo in pancreatic cancer, Verastem is mulling its R&D strategy.

Fraiser Kansteiner Jun 17, 2026 3:00pm

Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b

The top 10 pharma R&D budgets of 2025

Apr 10, 2026 9:28am

NVS

Novartis pledges nearly $480M to bolster China production, R&D

Mar 23, 2026 10:35am

As AI evolves, the modern R&D lab is changing

Mar 6, 2026 8:47am

Merck

Merck splits human pharma business, establishing oncology unit

Feb 23, 2026 10:25am

dollar sign pipeline

Fierce Biotech

Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg

Feb 13, 2026 10:10am